Defining a longevity biotechnology company
Nat Biotechnol
.
2023 Aug;41(8):1053-1055.
doi: 10.1038/s41587-023-01854-0.
Authors
Nicola Boekstein
1
,
Nir Barzilai
2
,
André Bertram
3
,
Joe Betts-LaCroix
4
,
Kristen Fortney
5
,
Stephen B Helliwell
6
,
Michael Hufford
7
,
Joan Mannick
8
,
Jerry McLaughlin
9
,
Jim Mellon
10
,
Eric Morgen
5
,
Nils Regge
11
,
Daisy A Robinton
12
,
David A Sinclair
13
,
Sergey Young
14
,
Risa Starr
15
,
Alex Zhavoronkov
16
,
James Peyer
17
Affiliations
1
Cambrian Bio, Inc., New York, NY, USA.
[email protected]
.
2
American Federation for Aging Research (AFAR), New York, NY, USA.
3
Bertram Endeavours, Toronto, Ontario, Canada.
4
Retro Biosciences, Inc., Redwood City, CA, USA.
5
BioAge Labs, Richmond, CA, USA.
6
Rejuveron, Zurich, Switzerland.
7
Lygenesis, Pittsburgh, PA, USA.
8
Tornado Therapeutics, Cambrian Bio Inc. PipeCo, New York, NY, USA.
9
Life Biosciences, Cambridge, MA, USA.
10
Juvenescence, Dublin, Ireland.
11
Apollo Health Ventures, Berlin, Germany.
12
Oviva Therapeutics, New York, NY, USA.
13
Genetics Department, Paul F. Glenn Center for Biology of Aging Research, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
14
Longevity Vision Fund, New York, NY, USA.
15
Longevity Biotechnology Association, New York, NY, USA.
16
Insilico Medicine Hong Kong Ltd, Hong Kong, Hong Kong.
17
Cambrian Bio, Inc., New York, NY, USA.
PMID:
37365260
DOI:
10.1038/s41587-023-01854-0
No abstract available
Publication types
Letter
MeSH terms
Biotechnology*